Extracorporeal photochemotherapy in systemic sclerosis and severe morphea

B Cribier, T Faradji, C Le Coz, F Oberling, E Grosshans - Dermatology, 1995 - karger.com
Background: Extracorporeal photochemotherapy (EP) is a new immune-modulating therapy
which combines cytapheresis and extracorporeal irradiation of leukocytes by UVA. Recently …

Extracorporeal photochemotherapy in progressive systemic sclerosis

FX DI SPALTRO, C COTTRILL… - International journal …, 1993 - Wiley Online Library
Background. Extracorporeal photochemotherapy, an immune‐modulating form of therapy,
has been shown to be effective in the treatment of autoimmune diseases. We evaluated the …

Extracorporeal photochemotherapy in progressive systemic sclerosis: a follow‐up study

J Schwartz, J Gonzalez, M Palangio… - International journal …, 1997 - Wiley Online Library
Background Extracorporeal photochemotherapy (photopheresis), an immune‐modulating
therapy, has been demonstrated to elicit a therapeutic response in the treatment of several …

Immunomodulatory effects of extracorporeal photochemotherapy in systemic sclerosis

G Papp, IF Horvath, S Barath, E Gyimesi, J Vegh… - Clinical …, 2012 - Elsevier
The aim of this study was to evaluate the clinical and immunomodulatory effects of
extracorporeal photochemotherapy (ECP) in systemic sclerosis (SSc). We enrolled 16 …

Extended extracorporeal photochemotherapy with extracorporeal administration of 8‐methoxypsoralen in systemic sclerosis. An Austrian single‐center study

RR Muellegger, A Hofer, W Salmhofer… - Photodermatology …, 2000 - Wiley Online Library
Background: Extracorporeal photochemotherapy (EXP) is an immunomodulating therapy
that has been used in a limited number of patients with systemic sclerosis (SSC) with …

Photopheresis: advances and use in systemic sclerosis

XA Zhou, J Choi - Current rheumatology reports, 2017 - Springer
Abstract Purpose of Review Extracorporeal photochemotherapy (photopheresis, ECP) is a
cell-based immunomodulatory treatment that separates leukocytes from peripheral blood …

Treatment of patients with systemic sclerosis with extracorporeal photochemotherapy (photopheresis)

DNH Enomoto, JR Mekkes, PMM Bossuyt… - Journal of the American …, 1999 - Elsevier
Background: Effective treatment modalities for systemic sclerosis, a life-threatening and
disabling disease, are still lacking. Possible efficacy of photopheresis has been reported in …

Extracorporeal photopheresis for systemic sclerosis: A meta‐analysis of randomized clinical trials

C Delbrück, T Gambichler, L Susok… - Dermatologic …, 2022 - Wiley Online Library
Abstract Systemic sclerosis (scleroderma)(SSc) is a rare autoimmune disorder characterized
by excessive production of collagen. Extracorporeal photopheresis (photochemotherapy …

The assessment of immune-regulatory effects of extracorporeal photopheresis in systemic sclerosis: a long-term follow-up study

G Papp, IF Horvath, E Gyimesi, S Barath, J Vegh… - Immunologic …, 2016 - Springer
The therapeutic options in systemic sclerosis (SSc) are limited mainly to the management of
complications, and decelerating fibrosis and preventing disease progression are still great …

Extracorporeal photochemotherapy for secondary chronic progressive multiple sclerosis: a pilot study

DP Besnier, D Chabannes, JMG Mussini… - Photodermatology …, 2002 - Wiley Online Library
Background/purpose: Extracorporeal photochemotherapy (ECP) has been proposed for the
treatment of various auto‐and allo‐immune reactions. However, a standard ECP regimen …